Evidence map›Paper›PMID 34025901›Full record

ReviewCurrent fungal infection reports2021

Emergence of Triazole Resistance in

Daiana Macedo, Florencia Leonardelli, Soledad Gamarra, Guillermo Garcia-Effron

Open access · greenAbstract readReview
In one paragraph

Review in Current fungal infection reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. One health (Amsterdam, Netherlands) · 2026
    Article
  2. Directed evolution of the pathogenic moldAntimicrobial agents and chemotherapy · 2026
    Article
  3. Article
  4. A One Health Perspective onJournal of fungi (Basel, Switzerland) · 2026
    Article
  5. Azole-ResistantJournal of fungi (Basel, Switzerland) · 2025
    Review
  6. The Dual PathogenJournal of fungi (Basel, Switzerland) · 2025
    Review
  7. Article
  8. Review
  9. Antifungal stewardship: the Latin American experience.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2023
    Review
  10. Clinical utility of antifungal susceptibility testing.JAC-antimicrobial resistance · 2022
    Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Daiana MacedoConsejo Nacional de Investigaciones Científicas y Tecnológicas, Santa Fe, Argentina.
Florencia LeonardelliLaboratorio de Micología y Diagnóstico Molecular, Cátedra de Parasitología y Micología, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina.
Soledad GamarraLaboratorio de Micología y Diagnóstico Molecular, Cátedra de Parasitología y Micología, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina.
Guillermo Garcia-EffronConsejo Nacional de Investigaciones Científicas y Tecnológicas, Santa Fe, Argentina.
Centro Científico Tecnológico - Santa Fe · ARNational University of the Littoral · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewAzole resistance in RECENT

findingsAzole resistance in SUMMARY: After a comprehensive literature review, it is clear that azole resistance in

Indexed as

AspergillusLatin AmericaResistanceTriazole

Identifiers

PMID34025901
PMCPMC8132279
OpenAlexW3162735160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.